EH
BSX icon

Equitable Holdings’s Boston Scientific BSX Stock Holding History

Equitable Holdings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
29,331
-28,134
-49% -$1.53M 0.01% 917
2026
Q1 		$5.18M Buy
57,465
+34,882
+154% +$2.79M 0.03% 422
2025
Q4 		$2.15M Buy
22,583
+3,958
+21% +$388K 0.01% 617
2025
Q3 		$1.82M Buy
18,625
+373
+2% +$38.6K 0.01% 649
2025
Q2 		$1.96M Buy
18,252
+1,238
+7% +$125K 0.02% 579
2025
Q1 		$1.72M Buy
17,014
+288
+2% +$29K 0.02% 557
2024
Q4 		$1.49M Buy
16,726
+274
+2% +$24.1K 0.01% 556
2024
Q3 		$1.38M Buy
16,452
+1,058
+7% +$83.4K 0.01% 590
2024
Q2 		$1.19M Sell
15,394
-1,350
-8% -$98.8K 0.01% 611
2024
Q1 		$1.15M Sell
16,744
-2,579
-13% -$166K 0.01% 586
2023
Q4 		$1.12M Buy
19,323
+352
+2% +$18.8K 0.01% 555
2023
Q3 		$1M Sell
18,971
-216
-1% -$11.3K 0.01% 539
2023
Q2 		$1.04M Buy
19,187
+369
+2% +$19.3K 0.01% 511
2023
Q1 		$941K Buy
18,818
+11
+0.1% +$518 0.02% 482
2022
Q4 		$870K Sell
18,807
-253
-1% -$11K 0.02% 480
2022
Q3 		$738K Buy
19,060
+173
+0.9% +$6.94K 0.01% 466
2022
Q2 		$704K Sell
18,887
-1,544
-8% -$62.9K 0.01% 482
2022
Q1 		$905K Buy
20,431
+12
+0.1% +$520 0.01% 429
2021
Q4 		$867K Sell
20,419
-3,961
-16% -$166K 0.01% 431
2021
Q3 		$1.06M Sell
24,380
-4,206
-15% -$186K 0.02% 367
2021
Q2 		$1.22M Buy
28,586
+6,426
+29% +$270K 0.02% 334
2021
Q1 		$856K Sell
22,160
-73
-0.3% -$2.76K 0.02% 382
2020
Q4 		$799K Sell
22,233
-737
-3% -$26.6K 0.02% 359
2020
Q3 		$878K Sell
22,970
-635
-3% -$24.5K 0.02% 326
2020
Q2 		$829K Sell
23,605
-763
-3% -$27.5K 0.02% 325
2020
Q1 		$795K Buy
24,368
+63
+0.3% +$2.46K 0.03% 299
2019
Q4 		$1.1M Buy
+24,305
New +$1.02M 0.03% 282

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Equitable Holdings's BSX Position: Q2 2026 in Review

Equitable Holdings reduced its Boston Scientific (BSX) stake by 49% in Q2 2026, selling an estimated $1.53M and leaving 29,331 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #917.

Equitable Holdings first reported a position in BSX in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.18M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Equitable Holdings held 29,331 shares of Boston Scientific worth $1.25M as of Q2 2026.
  • Equitable Holdings sold 28,134 Boston Scientific shares in Q2 2026, an estimated $1.53M.
  • Boston Scientific made up 0.01% of Equitable Holdings's portfolio in Q2 2026, its #917 holding.
  • Equitable Holdings first reported a position in Boston Scientific in Q4 2019 and has held it in 27 quarters since.
  • Equitable Holdings's Boston Scientific position peaked at $5.18M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.